Meningococcal Vaccines Market Report 2026
Download Free Sample Buy Now
Meningococcal Vaccines Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : January 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Meningococcal Vaccines Market Report 2026

Global Outlook – By Vaccine Type (Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine), By Serotype (Men Acwy, Men B/Bc, Men C), By Age Group (Infants, Children, Adolescents and Young Adults, Adults), By Distribution Channel (Pharmacies, Community Clinics, Public Health Agencies, Other Channels), By End user (Hospitals, Research, Academic Institutes) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Meningococcal Vaccines Market Overview

• Meningococcal Vaccines market size has reached to $4.26 billion in 2025

• Expected to grow to $6.58 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%

• Growth Driver: Impact Of Rising Healthcare Spending On Meningococcal Vaccines

• Market Trend: Pfizer's Comprehensive Meningococcal Vaccine With FDA Approval

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Meningococcal Vaccines Market?

Meningococcal vaccinations are vaccines that protect against Neisseria meningitidis, the bacteria responsible for meningitis and bloodstream infections. These vaccines help the immune system recognize and fight the bacteria before it causes illness. These are used to prevent severe, potentially life-threatening meningococcal disease, especially in high-risk groups such as adolescents, college students, and travelers.

The main types of meningococcal vaccines are meningococcal conjugate vaccine, polysaccharide vaccine, and subcapsular vaccine. Meningococcal conjugate vaccine refers to a compound made up of a polysaccharide antigen fused (conjugated) to a carrier molecule. The different serotypes include Men ACWY, Men B/Bc, and Men C, given to various age groups such as infants, children, adolescents, young adults, and adults, and distributed by pharmacies, community clinics, public health agencies, and others. These are used by various end-users, such as hospitals, research institutions, and academic institutes.

Meningococcal Vaccines Market Global Report 2026 Market Report bar graph

What Is The Meningococcal Vaccines Market Size and Share 2026?

The meningococcal vaccines market size has grown strongly in recent years. It will grow from $4.26 billion in 2025 to $4.65 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to introduction of meningococcal conjugate vaccines, rising incidence of meningitis outbreaks, government immunization campaigns, growing pediatric vaccination coverage, increased public health funding.

What Is The Meningococcal Vaccines Market Growth Forecast?

The meningococcal vaccines market size is expected to see strong growth in the next few years. It will grow to $6.58 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to advancements in vaccine technology, expansion of global immunization programs, increasing awareness of meningococcal disease, strategic partnerships and collaborations, growth in adolescent and young adult vaccination initiatives. Major trends in the forecast period include expansion of pediatric vaccination programs, development of broad-spectrum meningococcal vaccines, increased government immunization initiatives, rising awareness of meningococcal disease prevention, growth of school and college vaccination campaigns.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Meningococcal Vaccines Market Segmentation

1) By Vaccine Type: Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine

2) By Serotype: Men Acwy, Men B/Bc, Men C

3) By Age Group: Infants, Children, Adolescents and Young Adults, Adults

4) By Distribution Channel: Pharmacies, Community Clinics, Public Health Agencies, Other Channels

5) By End user: Hospitals, Research, Academic Institutes

Subsegments:

1) By Meningococcal Conjugate Vaccine: Quadrivalent Conjugate Vaccine (MenACWY), Bivalent Conjugate Vaccine

2) By Polysaccharide Vaccine: Meningococcal Polysaccharide Vaccine (MPSV4), Group C Polysaccharide Vaccine

3) By Subcapsular Vaccine: Meningococcal B Vaccine (MenB), Combination Subcapsular Vaccines

What Is The Driver Of The Meningococcal Vaccines Market?

An increase in healthcare spending is expected to propel the growth of the meningococcal vaccine market going forward. Healthcare refers to a residential care institution, nursing facility, intermediate care facility for people with mental illnesses, or intermediate care facility for people with mental retardation. The high expense of new vaccine generations compared to their predecessors has become a key factor in discussions about whether the benefits of the new vaccinations justify their prices. Assessing the complete social and economic advantages of vaccination is becoming an increasingly important area of investigation in the literature on valuing vaccination. For instance, in April 2025, according to an article published by the American Medical Association, a US-based professional association and lobbying group of physicians and medical students, Health spending in the U.S. increased by 7.5% in 2023 to $4.9 trillion or $14,570 per capita. This growth rate is significantly higher than the 4.6% rise in 2022. Therefore, an increase in healthcare spending is driving the growth of the meningococcal vaccine industry.

Key Players In The Global Meningococcal Vaccines Market

Major companies operating in the meningococcal vaccines market are Pfizer Inc.,GlaxoSmithKline plc,Sanofi Pasteur,Merck & Co. Inc.,Serum Institute of India Pvt. Ltd.,Bio-Manguinhos,Walvax Biotechnology Co. Ltd.,Bharat Biotech,Panacea Biotec Ltd.,CSL Limited,Minhai Biotechnology Co. Ltd.,Hualan Biological Engineering Inc.,Shenzhen Kangtai Biological Products Co. Ltd.,Chongqing Zhifei Biological Products Co. Ltd.,Incepta Pharmaceuticals Ltd.,Biological E. Limited,Biokangtai,Biomed Pvt Ltd.,Biocine SCL,Bavarian Nordic A/S

Global Meningococcal Vaccines Market Trends and Insights

Major companies operating in the meningococcal vaccines market are developing new vaccines for the prevention of serogroups to increase their profitability in the market. Meningococcal vaccines are preventive measures designed to protect individuals against infections caused by specific serogroups of the bacteria Neisseria meningitidis. For instance, in October 2023, Pfizer Inc., a US-based pharmaceutical company received approval from FDA for the vaccine PENBRAYA. PENBRAYA, with extensive serogroup coverage, is the most comprehensive U.S.-approved meningococcal vaccine, safeguarding against groups A, B, C, W, and Y. FDA approval is grounded in robust Phase 2 and 3 trial data, confirming non-inferior immunogenicity to Trumenba + Menveo across all serogroups, coupled with favorable safety. Pfizer's September 2022 announcement revealed positive outcomes from a Phase 3 trial, comparing PENBRAYA to existing licensed meningococcal vaccines in terms of safety, tolerability, and immunogenicity.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Meningococcal Vaccines Market?

In September 2023, Biovac Institute, a South Africa-based vaccine manufacturer, formed a partnership with EuBiologics Co., Ltd, to facilitate the technology transfer of meningitis vaccines. The collaboration aims to enhance local production capabilities, improve access to high-quality meningitis vaccines, and strengthen regional immunization programs while fostering innovation and growth in vaccine development. EuBiologics Co., Ltd is a South Korea-based biopharmaceutical company specializes in the research, development, and commercialization of vaccines for infectious diseases.

Regional Insights

North America was the largest region in the meningococcal vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the meningococcal vaccines market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Meningococcal Vaccines Market?

The meningococcal vaccines market consists of sales of conjugate vaccines, combination vaccines, serogroup B vaccine products, and other types. Values in this market are ‘pharmaceuticals’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Meningococcal Vaccines Market Report 2026?

The meningococcal vaccines market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the meningococcal vaccines industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Meningococcal Vaccines Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $4.65 billion
Revenue Forecast In 2035 $6.58 billion
Growth Rate CAGR of 9.3% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Vaccine Type, Serotype, Age Group, Distribution Channel, End user
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc.,GlaxoSmithKline plc,Sanofi Pasteur,Merck & Co. Inc.,Serum Institute of India Pvt. Ltd.,Bio-Manguinhos,Walvax Biotechnology Co. Ltd.,Bharat Biotech,Panacea Biotec Ltd.,CSL Limited,Minhai Biotechnology Co. Ltd.,Hualan Biological Engineering Inc
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Meningococcal Vaccines Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Meningococcal Vaccines Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Meningococcal Vaccines Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Meningococcal Vaccines Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Expansion Of Pediatric Vaccination Programs

4.2.2 Development Of Broad-Spectrum Meningococcal Vaccines

4.2.3 Increased Government Immunization Initiatives

4.2.4 Rising Awareness Of Meningococcal Disease Prevention

4.2.5 Growth Of School And College Vaccination Campaigns

5. Meningococcal Vaccines Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Research Institutes

5.3 Academic Institutes

5.4 Public Health Agencies

5.5 Pharmacies

6. Meningococcal Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Meningococcal Vaccines Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Meningococcal Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Meningococcal Vaccines Market Size, Comparisons And Growth Rate Analysis

7.3. Global Meningococcal Vaccines Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Meningococcal Vaccines Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Meningococcal Vaccines Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Meningococcal Vaccines Market Segmentation

9.1. Global Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine

9.2. Global Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Men Acwy, Men B/Bc, Men C

9.3. Global Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Infants, Children, Adolescents and Young Adults, Adults

9.4. Global Meningococcal Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pharmacies, Community Clinics, Public Health Agencies, Other Channels

9.5. Global Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Research, Academic Institutes

9.6. Global Meningococcal Vaccines Market, Sub-Segmentation Of Meningococcal Conjugate Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Quadrivalent Conjugate Vaccine (MenACWY), Bivalent Conjugate Vaccine

9.7. Global Meningococcal Vaccines Market, Sub-Segmentation Of Polysaccharide Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Meningococcal Polysaccharide Vaccine (MPSV4), Group C Polysaccharide Vaccine

9.8. Global Meningococcal Vaccines Market, Sub-Segmentation Of Subcapsular Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Meningococcal B Vaccine (MenB), Combination Subcapsular Vaccines

10. Meningococcal Vaccines Market Regional And Country Analysis

10.1. Global Meningococcal Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Meningococcal Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Meningococcal Vaccines Market

11.1. Asia-Pacific Meningococcal Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Meningococcal Vaccines Market

12.1. China Meningococcal Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Meningococcal Vaccines Market

13.1. India Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Meningococcal Vaccines Market

14.1. Japan Meningococcal Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Meningococcal Vaccines Market

15.1. Australia Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Meningococcal Vaccines Market

16.1. Indonesia Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Meningococcal Vaccines Market

17.1. South Korea Meningococcal Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Meningococcal Vaccines Market

18.1. Taiwan Meningococcal Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Meningococcal Vaccines Market

19.1. South East Asia Meningococcal Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Meningococcal Vaccines Market

20.1. Western Europe Meningococcal Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Meningococcal Vaccines Market

21.1. UK Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Meningococcal Vaccines Market

22.1. Germany Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Meningococcal Vaccines Market

23.1. France Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Meningococcal Vaccines Market

24.1. Italy Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Meningococcal Vaccines Market

25.1. Spain Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Meningococcal Vaccines Market

26.1. Eastern Europe Meningococcal Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Meningococcal Vaccines Market

27.1. Russia Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Meningococcal Vaccines Market

28.1. North America Meningococcal Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Meningococcal Vaccines Market

29.1. USA Meningococcal Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Meningococcal Vaccines Market

30.1. Canada Meningococcal Vaccines Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Meningococcal Vaccines Market

31.1. South America Meningococcal Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Meningococcal Vaccines Market

32.1. Brazil Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Meningococcal Vaccines Market

33.1. Middle East Meningococcal Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Meningococcal Vaccines Market

34.1. Africa Meningococcal Vaccines Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Meningococcal Vaccines Market, Segmentation By Vaccine Type, Segmentation By Serotype, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Meningococcal Vaccines Market Regulatory and Investment Landscape

36. Meningococcal Vaccines Market Competitive Landscape And Company Profiles

36.1. Meningococcal Vaccines Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Meningococcal Vaccines Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Meningococcal Vaccines Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sanofi Pasteur Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Serum Institute of India Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

37. Meningococcal Vaccines Market Other Major And Innovative Companies

Bio-Manguinhos, Walvax Biotechnology Co. Ltd., Bharat Biotech, Panacea Biotec Ltd., CSL Limited, Minhai Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Shenzhen Kangtai Biological Products Co. Ltd., Chongqing Zhifei Biological Products Co. Ltd., Incepta Pharmaceuticals Ltd., Biological E. Limited, Biokangtai, Biomed Pvt Ltd., Biocine SCL, Bavarian Nordic A/S

38. Global Meningococcal Vaccines Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Meningococcal Vaccines Market

40. Meningococcal Vaccines Market High Potential Countries, Segments and Strategies

40.1 Meningococcal Vaccines Market In 2030 - Countries Offering Most New Opportunities

40.2 Meningococcal Vaccines Market In 2030 - Segments Offering Most New Opportunities

40.3 Meningococcal Vaccines Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Meningococcal Vaccines Market, Overview Of Key Products - Product Examples
  • Table 2: Global Meningococcal Vaccines Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Meningococcal Vaccines Market, Supply Chain Analysis
  • Table 4: Global Meningococcal Vaccines Market, Major Raw Material Providers
  • Table 5: Global Meningococcal Vaccines Market, Major Resource Providers
  • Table 6: Global Meningococcal Vaccines Market, Major Manufacturers (Suppliers)
  • Table 7: Global Meningococcal Vaccines Market, Major Distributors And Channel Partners
  • Table 8: Global Meningococcal Vaccines Market, Key Technologies & Future Trends
  • Table 9: Global Meningococcal Vaccines Market, Major Trends
  • Table 10: Global Meningococcal Vaccines Market, Major End Users
  • Table 11: Global Meningococcal Vaccines Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Meningococcal Vaccines Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Meningococcal Vaccines Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Meningococcal Vaccines Market - TAM, US$ Billion, 2025
  • Table 15: Global Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Meningococcal Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Meningococcal Vaccines Market, Sub-Segmentation Of Meningococcal Conjugate Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Meningococcal Vaccines Market, Sub-Segmentation Of Polysaccharide Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Meningococcal Vaccines Market, Sub-Segmentation Of Subcapsular Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Meningococcal Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Meningococcal Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Meningococcal Vaccines Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Meningococcal Vaccines Market - Company Scoring Matrix
  • Table 99: Pfizer Inc. Financial Performance
  • Table 100: GlaxoSmithKline plc Financial Performance
  • Table 101: Sanofi Pasteur Financial Performance
  • Table 102: Merck & Co. Inc. Financial Performance
  • Table 103: Serum Institute of India Pvt. Ltd. Financial Performance
  • Table 104: Global Meningococcal Vaccines Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Meningococcal Vaccines Market, Competitive Dashboard
  • Table 106: Global Meningococcal Vaccines Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Meningococcal Vaccines Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030
  • Table 108: Global, Meningococcal Vaccines Market Size Gain ($ Billion), Segmentation By Serotype, 2025 – 2030
  • Table 109: Global, Meningococcal Vaccines Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

List Of Figures

    Figure 1: Global Meningococcal Vaccines Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Meningococcal Vaccines Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Meningococcal Vaccines Market, Supply Chain Analysis
  • Figure 4: Global Meningococcal Vaccines Market, Major Raw Material Providers
  • Figure 5: Global Meningococcal Vaccines Market, Major Resource Providers
  • Figure 6: Global Meningococcal Vaccines Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Meningococcal Vaccines Market, Major Distributors And Channel Partners
  • Figure 8: Global Meningococcal Vaccines Market, Key Technologies & Future Trends
  • Figure 9: Global Meningococcal Vaccines Market, Major Trends
  • Figure 10: Global Meningococcal Vaccines Market, Major End Users
  • Figure 11: Global Meningococcal Vaccines Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Meningococcal Vaccines Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Meningococcal Vaccines Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Meningococcal Vaccines Market - TAM, US$ Billion, 2025
  • Figure 15: Global Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Meningococcal Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Meningococcal Vaccines Market, Segmentation By End user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Meningococcal Vaccines Market, Sub-Segmentation Of Meningococcal Conjugate Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Meningococcal Vaccines Market, Sub-Segmentation Of Polysaccharide Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Meningococcal Vaccines Market, Sub-Segmentation Of Subcapsular Vaccine, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Meningococcal Vaccines Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Meningococcal Vaccines Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Meningococcal Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Meningococcal Vaccines Market, Segmentation By Serotype, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Meningococcal Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Meningococcal Vaccines Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Meningococcal Vaccines Market - Company Scoring Matrix
  • Figure 99: Pfizer Inc. Financial Performance
  • Figure 100: GlaxoSmithKline plc Financial Performance
  • Figure 101: Sanofi Pasteur Financial Performance
  • Figure 102: Merck & Co. Inc. Financial Performance
  • Figure 103: Serum Institute of India Pvt. Ltd. Financial Performance
  • Figure 104: Global Meningococcal Vaccines Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Meningococcal Vaccines Market, Competitive Dashboard
  • Figure 106: Global Meningococcal Vaccines Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Meningococcal Vaccines Market Size Gain ($ Billion), Segmentation By Vaccine Type, 2025 – 2030
  • Figure 108: Global, Meningococcal Vaccines Market Size Gain ($ Billion), Segmentation By Serotype, 2025 – 2030
  • Figure 109: Global, Meningococcal Vaccines Market Size Gain ($ Billion), Segmentation By Age Group, 2025 – 2030

Dental Sleep Medicine Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Dental Sleep Medicine Growth Trajectory: Key Forecasts and Strategic Insights

Dipeptide Peptidase 4 Inhibitors Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About Dipeptide Peptidase 4 Inhibitors Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Dipeptide Peptidase 4 Inhibitors Market Landscape: Advancements In Epilepsy Treatment Solutions By Leading Pharmaceutical Companies

Read More About Emerging Trends Redefining the Dipeptide Peptidase 4 Inhibitors Market Landscape: Advancements In Epilepsy Treatment Solutions By Leading Pharmaceutical Companies

Top Trends Driving Innovation and Change in the Gastroparesis Drugs Market: Development Of Innovative Gastroparesis Treatment

Read More About Top Trends Driving Innovation and Change in the Gastroparesis Drugs Market: Development Of Innovative Gastroparesis Treatment

Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Read More About Uncover TBRC’s strategic outlook on technological trends, regulatory factors, and market growth in transdermal drug delivery systems.

Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Read More About Explore forecast data, therapeutic advancements, and pipeline progress in TBRC’s Tuberous Sclerosis Drug Market report.

Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Read More About Gain insights into strategic developments and market forecasts for the tissue plasminogen activator market.

Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Read More About Explore the impact of innovative phytocine lines on the herbal medicine market in 2025.

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant...

Automatic Effluent Samplers Market Report 2026 - Global Outlook – By Product Type (Portable Samplers, Stationary Samplers), By Distribution Channel (Direct Sales, Distributors), By Application (Industrial Wastewater, Mun...

Underwater Drone Market Report 2026 - Global Outlook – By Vehicle Control Mode (Remotely Operated Vehicle, Autonomous Underwater Vehicles, Hybrid Vehicles), By Product Type (Micro, Small And Medium, Light Work-Class, Hea...

Veterinary Reference Laboratory Market Report 2026 - Global Outlook – By Services (Clinical Chemistry, Hematology, Immunodiagnostics, Urinalysis, Molecular Diagnostics, Other Services), By Animal Type (Companion Animals,...

Screenless Display Market Report 2026 - Global Outlook – By Type ( Visual Image, Retinal Display, Synaptic Interface), By Display Size ( Small Screenless Displays, Medium Screenless Displays, Large Screenless Displays), ...

Smart Thermostat Global Market Report 2025 – By Product (Connected Smart thermostat, Learning Smart Thermostat, Standalone Smart Thermostat), By Technology (Wi-Fi, Bluetooth, Zigbee, Other Technologies), By Application (...

Frequently Asked Questions

The Meningococcal Vaccines Market Report 2026 market was valued at $4.26 billion in 2025, increased to $4.65 billion in 2026, and is projected to reach $6.58 billion by 2030. request a sample here

The expected CAGR for the Meningococcal Vaccines Market Report 2026 market during the forecast period 2025–2030 is 9.1%. request a sample here

Major growth driver of the market includes: Impact Of Rising Healthcare Spending On Meningococcal Vaccines in the Meningococcal Vaccines Market Report 2026 market. For further insights on this market, request a sample here

The meningococcal vaccines market covered in this report is segmented –
1) By Vaccine Type: Meningococcal Conjugate Vaccine, Polysaccharide, Subcapsular Vaccine
2) By Serotype: Men Acwy, Men B/Bc, Men C
3) By Age Group: Infants, Children, Adolescents and Young Adults, Adults
4) By Distribution Channel: Pharmacies, Community Clinics, Public Health Agencies, Other Channels
5) By End user: Hospitals, Research, Academic Institutes Subsegments:
1) By Meningococcal Conjugate Vaccine: Quadrivalent Conjugate Vaccine (MenACWY), Bivalent Conjugate Vaccine
2) By Polysaccharide Vaccine: Meningococcal Polysaccharide Vaccine (MPSV4), Group C Polysaccharide Vaccine
3) By Subcapsular Vaccine: Meningococcal B Vaccine (MenB), Combination Subcapsular Vaccines request a sample here

Major trend in this market includes: Pfizer's Comprehensive Meningococcal Vaccine With FDA Approval For further insights on this market, request a sample here.

Major companies operating in the Meningococcal Vaccines Market Report 2026 market are Major companies operating in the meningococcal vaccines market are Pfizer Inc.,GlaxoSmithKline plc,Sanofi Pasteur,Merck & Co. Inc.,Serum Institute of India Pvt. Ltd., request a sample here.

North America was the largest region in the meningococcal vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the meningococcal vaccines market report during the forecast period. The regions covered in the meningococcal vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us